Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damian Fogarty

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Plos One|June 18, 2014
Inpatient coronary angiography and revascularisation following non-ST-elevation acute coronary syndrome in patients with renal impairment: a cohort study using the Myocardial Ischaemia National Audit ProjectCatriona Shaw, Dorothea Nitsch, Retha Steenkamp, et al.
Diabetes, Obesity & Metabolism|January 21, 2020
Comparative effects of sulphonylureas, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary careSamantha Wilkinson, Elizabeth Williamson, Ana Pokrajac, et al.
Diabetes Care|February 28, 2014
Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.KAmanda Adler, Anna Casula, Retha Steenkamp, et al.
Clinical Epidemiology|December 7, 2018
Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary careSamantha Wilkinson, Ian J Douglas, Elizabeth Williamson, et al.
Disease Markers|January 25, 2005
The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: analysis employing a family based approachPaul G McGlinchey, Mark S Spence, Chris C Patterson, et al.
Environmental Geochemistry and Health|June 26, 2020
Chronic kidney disease of unknown origin is associated with environmental urbanisation in Belfast, UKJennifer M McKinley, Ute Mueller, Peter M Atkinson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 30, 2020
Inequity in Access to Transplantation in the United KingdomRishi Pruthi, Matthew L Robb, Gabriel C Oniscu, et al.
Kidney International Reports|May 2, 2022
Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021Debasish Banerjee, Peter Winocour, Tahseen A Chowdhury, et al.
Kidney International|April 7, 2019
Limited health literacy is associated with reduced access to kidney transplantationDominic M Taylor, J Andrew Bradley, Clare Bradley, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2022
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney diseaseJanaka Karalliedde, Peter Winocour, Tahseen A Chowdhury, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Plos One|June 18, 2014
Inpatient coronary angiography and revascularisation following non-ST-elevation acute coronary syndrome in patients with renal impairment: a cohort study using the Myocardial Ischaemia National Audit ProjectCatriona Shaw, Dorothea Nitsch, Retha Steenkamp, et al.
Diabetes, Obesity & Metabolism|January 21, 2020
Comparative effects of sulphonylureas, dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary careSamantha Wilkinson, Elizabeth Williamson, Ana Pokrajac, et al.
Diabetes Care|February 28, 2014
Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.KAmanda Adler, Anna Casula, Retha Steenkamp, et al.
Clinical Epidemiology|December 7, 2018
Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary careSamantha Wilkinson, Ian J Douglas, Elizabeth Williamson, et al.
Disease Markers|January 25, 2005
The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: analysis employing a family based approachPaul G McGlinchey, Mark S Spence, Chris C Patterson, et al.
Environmental Geochemistry and Health|June 26, 2020
Chronic kidney disease of unknown origin is associated with environmental urbanisation in Belfast, UKJennifer M McKinley, Ute Mueller, Peter M Atkinson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 30, 2020
Inequity in Access to Transplantation in the United KingdomRishi Pruthi, Matthew L Robb, Gabriel C Oniscu, et al.
Kidney International Reports|May 2, 2022
Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021Debasish Banerjee, Peter Winocour, Tahseen A Chowdhury, et al.
Kidney International|April 7, 2019
Limited health literacy is associated with reduced access to kidney transplantationDominic M Taylor, J Andrew Bradley, Clare Bradley, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 26, 2022
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney diseaseJanaka Karalliedde, Peter Winocour, Tahseen A Chowdhury, et al.
Pageof 5